FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

764842006: Prolonged-release ocular implant (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3655266013 Prolonged-release ocular implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3655267016 Prolonged-release ocular implant (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release ocular implant Is a Ocular dose form (dose form) false Inferred relationship Some
Prolonged-release ocular implant Has dose form administration method (attribute) A method of administration of a dose form by being placed into a body cavity. false Inferred relationship Some
Prolonged-release ocular implant Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release ocular implant Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration to the eye or eye structures. false Inferred relationship Some
Prolonged-release ocular implant Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release ocular implant Has basic dose form (attribute) Implant true Inferred relationship Some
Prolonged-release ocular implant Has dose form administration method (attribute) A method of administration of a dose form by being placed within a tissue of the body. true Inferred relationship Some
Prolonged-release ocular implant Is a Intraocular dose form true Inferred relationship Some
Prolonged-release ocular implant Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration into the eyeball structure. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Has manufactured dose form True Prolonged-release ocular implant Inferred relationship Some
Fluocinolone 0.59mg ocular implant Has manufactured dose form False Prolonged-release ocular implant Inferred relationship Some
Dexamethasone 700 microgram prolonged-release ocular implant Has manufactured dose form True Prolonged-release ocular implant Inferred relationship Some
Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug) Has manufactured dose form True Prolonged-release ocular implant Inferred relationship Some
Prolonged-release intravitreal implant (dose form) Is a True Prolonged-release ocular implant Inferred relationship Some
Prolonged-release intracameral implant (dose form) Is a True Prolonged-release ocular implant Inferred relationship Some

Reference Sets

GB English

US English

Back to Start